164 related articles for article (PubMed ID: 1831577)
1. Provocation tests in a chlormezanone-induced fixed drug eruption.
Lee AY; Lee YS
DICP; 1991 Jun; 25(6):604-5. PubMed ID: 1831577
[TBL] [Abstract][Full Text] [Related]
2. Topical provocation of fixed drug eruption. A study of 30 patients.
Alanko K
Contact Dermatitis; 1994 Jul; 31(1):25-7. PubMed ID: 7924289
[TBL] [Abstract][Full Text] [Related]
3. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years.
Lee AY
Contact Dermatitis; 1998 May; 38(5):258-60. PubMed ID: 9667442
[TBL] [Abstract][Full Text] [Related]
4. Topical provocation of fixed drug eruption.
Alanko K; Stubb S; Reitamo S
Br J Dermatol; 1987 Apr; 116(4):561-7. PubMed ID: 2953388
[TBL] [Abstract][Full Text] [Related]
5. Topical provocation in fixed drug eruption due to metamizol and naproxen.
Ozkaya-Bayazit E
Clin Exp Dermatol; 2004 Jul; 29(4):419-22. PubMed ID: 15245546
[TBL] [Abstract][Full Text] [Related]
6. Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.
Ben Romdhane H; Ammar H; Ben Fadhel N; Chadli Z; Ben Fredj N; Boughattas NA; Chaabane A; Aouam K
Contact Dermatitis; 2019 Jul; 81(1):24-26. PubMed ID: 30663057
[TBL] [Abstract][Full Text] [Related]
7. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
[TBL] [Abstract][Full Text] [Related]
8. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption.
Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
Contact Dermatitis; 1999 Oct; 41(4):185-9. PubMed ID: 10515095
[TBL] [Abstract][Full Text] [Related]
9. Fixed drug eruption caused by chlormezanone.
Mohamed KN
Int J Dermatol; 1983 Nov; 22(9):548. PubMed ID: 6227574
[No Abstract] [Full Text] [Related]
10. Fixed drug eruption: topical provocation and subsequent phenomena.
Mahboob A; Haroon TS; Iqbal Z; Iqbal F; Saleemi MA; Munir A
J Coll Physicians Surg Pak; 2006 Dec; 16(12):747-50. PubMed ID: 17125631
[TBL] [Abstract][Full Text] [Related]
11. Fixed drug eruption caused by chlormezanone.
Rademacher D; Gerhardt G; Brasch J
Contact Dermatitis; 1995 Feb; 32(2):117-8. PubMed ID: 7758315
[No Abstract] [Full Text] [Related]
12. Fixed drug eruption due to a drug combination but not to its constituents.
Verbov J
Dermatologica; 1985; 171(1):60-1. PubMed ID: 3161760
[TBL] [Abstract][Full Text] [Related]
13. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
Cravo M; Gonçalo M; Figueiredo A
Int J Dermatol; 2007 Jul; 46(7):760-2. PubMed ID: 17614812
[TBL] [Abstract][Full Text] [Related]
14. Fixed drug eruption following metronidazole therapy and the use of topical provocation testing in diagnosis.
Short KA; Fuller LC; Salisbury JR
Clin Exp Dermatol; 2002 Sep; 27(6):464-6. PubMed ID: 12372086
[TBL] [Abstract][Full Text] [Related]
15. Probable etoricoxib-induced fixed drug eruption involving the oral mucosa: A case report.
Perks A; Bates TJ; Velangi S; Brown RM; Poveda-Gallego A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Apr; 131(4):e100-e107. PubMed ID: 33468439
[TBL] [Abstract][Full Text] [Related]
16. Fixed drug eruption to ingested propolis.
Ramien ML; Pratt MD
Dermatitis; 2012; 23(4):173-5. PubMed ID: 22828258
[TBL] [Abstract][Full Text] [Related]
17. Fixed drug eruption due to chlormezanone.
McFadden N
Dermatologica; 1988; 176(2):106. PubMed ID: 2967209
[No Abstract] [Full Text] [Related]
18. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
Calistru AM; Cunha AP; Nogueira A; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
[TBL] [Abstract][Full Text] [Related]
19. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S; John AM; Handler MZ; Schwartz RA
Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
[TBL] [Abstract][Full Text] [Related]
20. Fixed drug eruption from piroxicam.
Cuerda Galindo E; Goday Buján JJ; García Silva JM; Martínez W; Verea Hernando M; Fonseca E
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):586-7. PubMed ID: 15324401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
